Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Change in Account Payables (2010 - 2026)

Palatin Technologies' (PTN) quarterly Change in Account Payables came in at -$8558.0 in Q1 2026, down 100.81% YoY from $1.1 million in Q1 2025, and up 99.56% on a QoQ basis from -$2.0 million in Q4 2025.

Palatin Technologies (PTN) Change in Account Payables (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 17 years of Change in Account Payables data on file, last reported at -$8558.0 in Q1 2026.

  • Quarterly Change in Account Payables fell 100.81% year-over-year to -$8558.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.3 million (down 153.75% YoY) and the FY2025 annual result came in at $2.9 million, up 1536.96% from the prior year.
  • Change in Account Payables rose to -$8558.0 in Q1 2026, from -$2.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.8 million in Q4 2024 to a low of -$3.1 million in Q4 2022.
  • A 5-year average of $311980.2 and a median of $658682.0 in 2024 frame the typical range for Change in Account Payables.
  • The widest YoY moves for Change in Account Payables: up 822.29% in 2022, down 407.2% in 2022.
  • Tracing PTN's Change in Account Payables over 5 years: stood at -$3.1 million in 2022, then soared by 77.88% to -$676164.0 in 2023, then surged by 509.55% to $2.8 million in 2024, then sank by 170.52% to -$2.0 million in 2025, then soared by 99.56% to -$8558.0 in 2026.
  • The last three Change in Account Payables figures came in at -$8558.0 (Q1 2026), -$2.0 million (Q4 2025), and $407043.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Palatin Technologies 40.37 Mn 40.37 Mn - -8,558.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -8,558.00
Mar 31, 2026 -8,558.00
Dec 31, 2025 -1.95 Mn
Dec 31, 2025 -1.95 Mn
Sep 30, 2025 407,043.00
Sep 30, 2025 407,043.00
Jun 30, 2025 -771,761.00
Jun 30, 2025 -771,761.00
Mar 31, 2025 1.05 Mn
Mar 31, 2025 1.05 Mn
Dec 31, 2024 2.77 Mn
Dec 31, 2024 2.77 Mn
Sep 30, 2024 -152,901.00
Sep 30, 2024 -152,901.00
Jun 30, 2024 658,682.00
Jun 30, 2024 658,682.00
Mar 31, 2024 1.85 Mn
Mar 31, 2024 1.85 Mn
Dec 31, 2023 -676,164.00
Dec 31, 2023 -676,164.00